Puberty, steroids and GABAA receptor plasticity

Psychoneuroendocrinology

Volumn 34, Issue SUPPL. 1, 2009, Pages

  Smith, Sheryl S ^a   Aoki, Chiye ^b   Shen, Hui ^a  

^a SUNY Downstate Medical Center   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Allopregnanolone; Anxiety; CA1 hippocampus; Chloride; GABAA receptor; Neurosteroid; Pregnanolone; Puberty; Steroid withdrawal; Stress; Tonic current

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; 4 AMINOBUTYRIC ACID A RECEPTOR; ARGININE; CHLORIDE ION; CORTICOSTERONE; FINASTERIDE; GABOXADOL; PROGESTERONE; RECEPTOR SUBTYPE; STEROID;

ANTICONVULSANT ACTIVITY; ANXIETY; ARTICLE; CELL STRAIN HEK293; CENTRAL NERVOUS SYSTEM; CHLORIDE TRANSPORT; FEMALE; GENE MUTATION; HIPPOCAMPUS; HUMAN; MAZE TEST; MENTAL STRESS; MOOD CHANGE; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NONHUMAN; OVARY CYCLE; PREGNANCY; PREMENSTRUAL DYSPHORIC DISORDER; PRESYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBERTY; PYRAMIDAL NERVE CELL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TRANQUILIZING ACTIVITY; VOLTAGE CLAMP;

ANIMALS; ANXIETY; CA1 REGION, HIPPOCAMPAL; CORTICOSTERONE; FEMALE; FINASTERIDE; GABA AGENTS; HUMANS; MEMBRANE POTENTIALS; MICE; MICE, TRANSGENIC; NEURAL INHIBITION; NEURONAL PLASTICITY; NEUROTRANSMITTER AGENTS; PERIAQUEDUCTAL GRAY; PREGNANOLONE; PREMENSTRUAL SYNDROME; PROGESTERONE; PUBERTY; PYRAMIDAL CELLS; RATS; RECEPTORS, GABA-A; STRESS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 71249131627     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.05.011     Document Type: Article

References (135)

1. Agis-Balboa R.C., Pinna G., Zhubi A., Maloku E., Veldic M., Costa E., and Guidotti A. Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc. Natl. Acad. Sci. 103 (2006) 14602-14607
2. Akwa Y., Purdy R.H., Koob G.F., and Britton K.T. The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav. Brain Res. 106 (1999) 119-125
3. Andreen L., Sundstrom-Poromaa I., Bixo M., Andersson A., Nyberg S., and Backstrom T. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone. Psychoneuroendocrinology 30 (2004) 212-224
4. Apter D., and Hermanson E. Update on female pubertal development. Curr. Opin. Obstet. Gynecol. 14 (2002) 475-481
5. Bai D., Zhu G., Pennefather P., Jackson M.F., Macdonald J.F., and Orser B.A. Distinct functional and pharmacological properties of tonic and quantal inhibitory postsynaptic currents mediated by γ-aminobutyric acid (A) receptors in hippocampal neurons. Mol. Pharmacol. 59 (2000) 814-824
6. Barbaccia M.L., Concas A., Roscetti G., Bolacchi F., Mostallino M.C., Purdy R.H., and Biggio G. Stress-induced increase in brain neuroactive steroids: antagonist by abercarnil. Pharmacol. Biochem. Behav. 54 (1996) 205-210
7. Barrera N.P., Betts T., You H., Henderson R.M., Martin I.L., Dunn S.M., and Edwardson J.M. Atomic force microscopy reveals the stoichiometry and subunit arrangement of the α4β3δ GABA(A) receptor. Mol. Pharmacol. 73 (2008) 960-967
8. Belelli D., Casula A., Ling A., and Lambert J.J. The influence of subunit composition on the interaction of neurosteroids with GABA (A) receptors. Neuropharmacology 43 (2002) 651-661
9. A receptor-mediated inhibitory neurotransmission in the rat hippocampus: evidence for endogenous neurosteroids?. J. Neurosci. 23 (2003) 10013-10020
10. Belelli D., Peden D.R., Rosahl T.W., Wafford K., and Lambert J.J. Extrasynaptic GABA-A receptors for thalamocortical neurons: a molecular target for hypnotics. J. Neurosci. 25 (2005) 11513-11520
11. Bianchi M.T., Haas K.F., and Macdonald R.L. Alpha1 and alpha6 subunits specify distinct desensitization, deactivation and neurosteroid modulation of GABA (A) receptors containing the delta subunit. Neuropharmacology 43 (2002) 492-502
12. Bianchi M.T., and Macdonald R.L. Neurosteroids shift partial agonist activation of GABA (A) receptor channels from low- to high-efficacy gating patterns. J. Neurosci. 23 (2003) 10934-10943
13. Birnsteil S., List T.J., and Beck S.G. Chronic corticosterone treatment maintains synaptic activity of CA1 hippocampal pyramidal cells: acute high corticosterone administration increases action potential number. Synapse 20 (1995) 117-124
14. Bitran D., Dugan M., Renda P., Ellis R., and Foley M. Anxiolytic effects of the neuroactive steroid pregnanolone (3alpha-OH-5beta-pregnan-20-one) after microinjection in the dorsal hippocampus and lateral septum. Brain Res. 850 (1999) 217-224
15. A receptor function. Brain Res. 561 (1993) 157-161
16. Brack K.E., and Lovick T.A. Neuronal excitability in the periaqueductal grey matter during the estrous cycle in female Wistar rats. Neuroscience (2006) (epub October 10)
17. Brickley S.G., Revilla V., Cull-Candy S.G., Wisden W., and Farrant M. Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature 409 (2001) 88-92
18. Brown N., Kerby J., Bonnert T.P., Whiting P.J., and Wafford K.A. Pharmacological characterization of a novel cell line expressing human alpha (4)beta (3)delta GABA (A) receptors. Br. J. Pharmacol. 136 (2002) 965-974
19. Buchanan C.M., Eccles J.S., and Becker J.B. Are adolescents the victims of raging hormones: evidence for activational effects of hormones on moods and behavior at adolescence. Psychol. Bull. 111 (1992) 62-107
20. Burgard E.C., Tietz E.I., Neelands T.R., and Macdonald R.L. Properties of recombinant gamma-aminobutyric acid A receptor isoforms containing the alpha 5 subunit subtype. Mol. Pharmacol. 50 (1996) 119-127
21. Cagetti E., Liang J., Spigelman I., and Olsen R.W. Withdrawal from chronic intermittent ethanol treatment changes subunit composition, reduces synaptic function, and decreases behavioral responses to positive allosteric modulators of GABA(A) receptors. Mol. Pharmacol. 63 (2003) 53-64
22. Caraiscos V.B., Elliott E.M., You-Ten K.E., Cheng V.Y., Belelli D., Newell J.G., Jackson M.F., Lambert J.J., Rosahl T.W., Wafford K., MacDonald J.F., and Orser B.A. Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by alpha 5 subunit-containing gamma-aminobutyric acid type A receptors. Proc. Natl. Acad. Sci. 101 (2004) 3662-3667
23. Chameau P., Qin Y., Spijker S., Smit G., and Joels M. Glucocorticoids specifically enhance L-type calcium current amplitude and affect calcium channel subunit expression in the mouse hippocampus. J. Neurophysiol. 97 (2007) 5-14
24. Chandra D., Jia F., Liang J., Peng Z., Suryanarayanan A., Werner D.F., Spigelman I., House C.R., Olsen R.W., Harrison N.L., and Homanics G.E. GABA(A) receptor alpha-4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc. Natl. Acad. Sci. 103 (2006) 15230-15235
25. Chang Y., Wang R., Barot S., and Weiss D.S. Stoichiometry of a recombinant GABA-A receptor. J. Neurosci. 16 (1990) 534-541
26. Chen J., Mitcheson J.S., Lin M., and Sanguinetti M.C. Functional roles of charged residues in the putative voltage sensor of the HCN2 pacemaker channel. J. Biol. Chem. 275 (2000) 36465-36471
27. Corpechot C., Collins B., Carey M., Tsouros A., Robel P., and Fry J. Brain neurosteroids during the mouse oestrous cycle. Brain Res. 766 (1997) 276-280
28. Costello E.J., Sung M., Worthman C., and Angold A. Pubertal maturation and the development of alcohol use and abuse. Drug Alcohol Depend. 88 Suppl. 1 (2007) S50-S59
29. A receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. J. Neurochem. 69 (1997) 126-130
30. Drooglever Fortuyn H.A., van Broekhoven F., Span P.N., Backstrom T., Zitman F.G., and Verkes R.J. Effects of Ph.D. examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor density. Psychoneuroendocrinology 29 (2004) 1341-1344
31. Dunn S.M.J., Tancowny B., and Martin I.L. Characterisation of GABA-A receptors containing alpha4-beta1-delta subunits. J. Physiol. 548P (2003) 5P
32. Endicott J., Amsterdam J., Eriksson E., Frank E., Freeman E., Hirschfeld R., Ling F., Parry B., Pearlstein T., Rosenbaum J., Rubinow D., Schmidt P., Severino S., Steiner M., Stewaart D., and Thys-Jacobs S. Is premenstrual dysphoric disorder a distinct clinical entity?. J. Womens Health Gend. Based Med. 8 (1999) 663-679
33. Fadalti M., Petraglia F., Luisi S., Bernardi F., Casarosa E., Ferrari E., Luisi M., Saggese G., Genazzani A.R., and Bernasconi S. Changes of serum allopregnanolone levels in the first 2 years of life and during pubertal development. Pediatr. Res. 46 (1999) 323-327
34. Fancsik A., Linn D.M., and Tasker J.G. Neurosteroid modulation of GABA IPSCs is phosphorylation dependent. J. Neurosci. 20 (2000) 3067-3075
35. Feng H.J., Kang J.Q., Song L., Dibbens L., Mulley J., and Macdonald R.L. Delta subunit susceptibility variants E177A and R220H associated with complex epilepsy alter channel gating and surface expression of alpha4beta2delta GABA-A receptors. J. Neurosci. 26 (2006) 1499-1506
36. Follesa P., Cagetti E., Mancuso L., Biggio F., Manca A., Maciocco E., Massa F., Desole M., Carta M., Busonero F., Sanna E., and Biggio G. Increase in expression of the GABA (A) receptor alpha (4) subunit gene induced by withdrawal of, but not by long-term treatment with, benzodiazepine full or partial agonists. Brain Res. Mol. Brain Res. 92 (2001) 138-148
37. Follesa P., Mancuso L., Biggio F., Cagetti E., Franco M., Trapani G., and Biggio G. Changes in GABA (A) receptor gene expression induced by withdrawal of, but not by long-term exposure to, zaleplon or zolpidem. Neuropharmacology 42 (2002) 191-198
38. Freeman E.W., Frye C.A., Rickels K., Martin P.A., and Smith S.S. Allopregnanolone levels and symptom improvement in severe premenstrual syndrome. J. Clin. Psychopharmacol. 22 (2002) 516-520
39. Frye C.A. The neurosteroid 3α,5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy. Brain Res. 696 (1995) 113-120
40. Frye C.A., Paris J.J., and Rhodes M.E. Increasing 3alpha,5alpha-THP following inhibition of neurosteroid biosynthesis in the ventral tegmental area reinstates anti-anxiety, social and sexual behavior of naturally receptive rats. Reproduction 137 (2009) 119-128
41. A receptor gating kinetics on the alpha subunit isoform: implications for structure-function relations and synaptic transmission. J. Physiol. 489 (1995) 529-543
42. Girdler S.S., Beth Mechlin M., Light K.C., and Morrow A.L. Ethnic differences in allopregnanolone concentrations in women during rest and following mental stress. Psychophysiology 43 (2006) 331-336
43. Glykys J., Peng Z., Chandra D., Homanics G.E., Houser C.R., and Mody I. A new naturally occurring GABA-A receptor subunit partnership with high sensitivity to ethanol. Nat. Neurosci. 10 (2007) 40-48
44. Glykys J., and Mody I. The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus. J. Physiol. 582 (2007) 1163-1178
45. Goldstein D.S., and Kopin I.J. Adrenomedullary, adrenocortical and sympathoneural responses to stressors: a meta-analysis. Endocr. Regul. 42 (2008) 111-119
46. Griffiths J., and Lovick T. Withdrawal from progesterone increases expression of alpha4, beta1 and delta GABA (A) receptor subunits in neurons in the periaqueductal gray matter in female Wistar rats. J. Comp. Neurol. 486 (2005) 89-97
47. Guo A.L., Petraglia F., Criscuolo M., Ficarra G., Nappi R.E., Palumbo M.A., Trentini G.P., Purdy R.H., and Gennazani A.R. Evidence for a role of neurosteroids in modulation of diurnal changes and acute stress-induced corticosterone secretion in rats. Gynecol. Endocrinol. 9 (1995) 1-7
48. A receptor currents in mouse fibroblasts. J. Physiol. 514 (1999) 27-45
49. Halbreich U., Backstrom T., Eriksson E., O'Brien S., Calil H., Ceskova E., Dennerstein L., Douki S., Freeman E.W., Genazzani A.R., Heuser I., Kadri N., Rapkin A., Steiner M., Wittchen H.U., and Yonkers K.A. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecol. Endocrinol. 23 (2007) 123-130
50. Hamann M., Rossi D.J., and Attwell D. Tonic and spillover inhibition of granule cells control information flow through cerebellar cortex. Neuron 33 (2002) 625-633
51. A receptors in rat CA1 and dentate gyrus neurones. Neuropharmacology 45 (2003) 873-883
52. Hayward C., and Sanborn K. Puberty and the emergence of gender differences in psychopathology. J. Adolesc. Health 30S (2002) 49-58
53. Herd M.B., Haythornthwaite A.R., Rosahl T.W., Wafford K., Homanics G.E., Lambert J.J., and Belelli D. The expression of GABA-A beta subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells. J. Physiol. 586 (2008) 989-1004
54. A channel subtypes. Mol. Neurobiol. 18 (1998) 35-86
55. Higashi T., Takido N., and Shimada K. Studies on neurosteroids XVII. Analysis of stress-induced changes in neurosteroid levels in rat brains using liquid chromatography-electron capture atmospheric pressure chemical ionization-mass spectrometry. Steroids 70 (2005) 1-11
56. Holsboer F., and Ising M. Central CRH system in depression and anxiety-evidence from clinical studies with CRH1 receptor antagonists. Eur. J. Pharmacol. 583 (2008) 350-357
57. A receptor subunit mRNAs in the rat cortex. Neuropharmacology 35 (1996) 1457-1463
58. Holt R.A., Bateson A.N., and Martin I.L. Chronic zolpidem treatment alters GABA (A) receptor mRNA levels in the rat cortex. Eur. J. Pharmacol. 329 (1997) 129-132
59. Hosie A.M., Wilkins M.E., da Silva H.M., and Smart T.G. Endogenous neurosteroids regulate GABA-A receptors through two discrete transmembrane sites. Nature 444 (2006) 486-489
60. Hsu F.-C., and Smith S.S. Progesterone withdrawal reduces paired-pulse inhibition in rat hippocampus: dependence on GABA-A receptor alpha-4 upregulation. J. Neurophysiol. 89 (2003) 186-198
61. Hsu F.-C., Waldeck R., Faber D.S., and Smith S.S. Neurosteroid effects on GABAergic synaptic plasticity in hippocampus. J. Neurophysiol. 89 (2003) 1929-1940
62. Huerta R., and Brizuela-Gamino O.L. Interaction of pubertal status, mood and self-esteem in adolescent girls. J. Reprod. Med. 47 (2002) 217-225
63. Hunter R.G., Bellani R., Bloss E., Costa A., McCarthy K., and McEwen B.S. Regulation of kainate receptor subunit mRNA by stress and corticosteroids in the rat hippocampus. PLoS ONE 4 (2009) e4328
64. Jia F., Pignataro L., Schofield C.M., Yue M., Harrison N.L., and Goldstein P.A. An extrasynaptic GABA-A receptor mediates tonic inhibition in thalamic VB neurons. J. Neurophysiol. 94 (2005) 4491-4501
65. Kahn A., Berger R.G., and de Catanzaro D. The onset of puberty in female mice as reflected in urinary steroids and uterine/ovarian mass: interactions of exposure to males, phytoestrogen content of diet, and ano-genital distance. Reproduction 235 (2008) 99-106
66. Kask K., Backstrom T., Lundgren P., and Sundstrom-Poromaa I. Allopregnanolone has no effect on startle response and prepulse inhibition of startle response in patients with premenstrual dysphoric disorder or healthy controls. Pharmacol. Biochem. Behav. (2009) (epub March 4)
67. Kelley S.P., Dunlop J.I., Kirkness E., Lambert J.J., and Peters J.A. A cytoplasmic region determines single-channel conductance in 5-HT3 receptors. Nature 424 (2003) 321-324
68. Lancel M., Faulhaber J., Schiffelholz T., Romeo E., Di Michele F., Holsboer F., and Rupprecht R. Allopregnanolone affects sleep in a benzodiazepine-like fashion. J. Pharmacol. Exp. Ther. 282 (1997) 1213-1218
69. A receptor channels are dependent on α-subunit isoform. Biophys. J. 73 (1997) 1-9
70. Le Melledo J.M., Van Driel M., Coupland N.J., Lott P., and Jhangri G.S. Response to flumazenil in women with premenstrual dysphoric disorder. Am. J. Psychiatry 157 (2000) 821-823
71. Liang J., Cagetti E., Olsen R.W., and Spigelman I. Altered pharmacology of synaptic and extrasynaptic GABA-A receptors on CA1 hippocampal neurons is consistent with subunit changes in a model of alcohol withdrawal and dependence. J. Pharmacol. Exp. Ther. 310 (2004) 1234-1245
72. A receptor alpha 4 subunit deletion on synaptic and extrasynaptic currents in mouse dentate granule cells. Alcohol. Clin. Exp. Res. 32 (2008) 19-26
73. Lo M., and Snyder S.H. Two distinct solubilized benzodiazepine receptors: differential modulation by ions. J. Neurosci. 3 (1983) 2270-2279
74. Lovick T. Panic disorder: a malfunction of multiple transmitter control systems within the midbrain periaqueductal gray matter?. Neuroscientist 6 (2000) 48-59
75. Lovick T.A., Griffiths J.L., Dunn S.M., and Martin I.L. Changes in GABA (A) receptor subunit expression in the midbrain during the oestrous cycle in Wistar rats. Neuroscience 131 (2005) 397-405
76. Lundgren P., Stromberg J., Backstrom T., and Wang M. Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3beta-hydroxy-5alpha-pregnan-20-one (isoallopregnanolone). Brain Res. 982 (2003) 45-53
77. Maggio N., and Segal M. Differential corticosteroid modulation of inhibitory synaptic currents in the dorsal and ventral hippocampus. J. Neurosci. 29 (2009) 2857-2866
78. Maguire J.L., and Mody I. Neurosteroid synthesis-mediated regulation of GABA (A) receptors: relevance to the ovarian cycle and stress. J. Neurosci. 27 (2007) 2155-2162
79. Maguire J.L., and Mody I. GABA(A)R plasticity during pregnancy: relevance to postpartum depression. Neuron 59 (2009) 207-213
80. Maguire J.L., Stell B.M., Rafizadeh M., and Mody I. Ovarian cycle-linked changes in GABA (A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety. Nat. Neurosci. 8 (2005) 797-804
81. A receptor α4 subunit expression-possible relevance to alcohol dependence. J. Neurochem. 68 (1997) 2485-2492
82. Majewska M.D., Harrison N.L., Schwartz R.D., Barker J.L., and Paul S.M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232 (1986) 1004-1007
83. McCartney C.R., et al. Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls. J. Clin. Endocrinol. Metab. 92 (2007) 430-436
84. McEwen B.S. Stressed or stressed out: what is the difference?. J. Psychiatry Neurosci. 30 (2005) 315-318
85. Mellon S.H., and Vaudry H. Biosynthesis of neurosteroids and regulation of their synthesis. Int. Rev. Neurobiol. 46 (2001) 33-78
86. Mihalek R.M., Banerjee P.K., Korpi E.R., Quinlan J.J., Firestone L.L., Mi Z.P., Lagenaur C., Tretter V., Sieghart W., Anagnostaras S.G., Sage J.R., Fanselow M.S., Guidotti A., Spigelman I., Li Z.W., DeLorey T.M., Olsen R.W., and Homanics G.E. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyric acid type A receptor delta subunit knockout mice. Proc. Natl. Acad. Sci. 96 (1999) 12905-12910
87. Miyazawa A., Fujiyoshi Y., and Unwin N. Structure and gating mechanism of the acetylcholine receptor pore. Nature 424 (2003) 949-955
88. Modesti P.A., Pela I., Cecioni I., Gensini G.F., Serneri G.G., and Bartolozzi G. Changes in blood pressure reactivity and 24-hour blood pressure profile occurring at puberty. Angiology 45 (2006) 443-450
89. Mtchedlishvili Z., and Kapur J. High-affinity, slowly desensitizing GABA-A receptors mediate tonic inhibition in hippocampal dentate granule cells. Mol. Pharmacol. 69 (2006) 564-575
90. Mukai H., Higashi T., Nagura Y., and Shimada K. Studies on neurosteroids XXV. Influence of 5alpha-reductase inhibitor, finasteride, on rat brain neurosteroid levels and metabolism. Biol. Pharm. Bull. 31 (2008) 1646-1650
91. Olijslagers J.E., de Kloet E.R., Elgersma Y., van Woerden G.M., Joels M., and Karst H. Rapid changes in hippocampal CA1 pyramidal cell function via pre- as well as postsynaptic membrane mineralocorticoid receptors. Eur. J. Neurosci. 27 (2008) 2542-2550
92. Olsen R.W., and Sieghart W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid (A) receptors: classification on the basis of subunit composition, pharmacology and function. Pharmacol. Rev. 60 (2008) 243-260
93. Olsen R.W., and Snowman A. Chloride-dependent enhancement by barbiturates of gamma-aminobutyric acid receptor binding. J. Neurosci. 2 (1982) 1812-1823
94. Palumbo M.A., Salvestroni C., Gallo R., Guo A.L., Gennazini A.D., Artini P.G., Petraglia F., and Gennazani A.R. Allopregnanolone concentration in hippocampus of prepubertal rats and female rats throughout estrous cycle. J. Endocrinol. Invest. 18 (1995) 853-856
95. Pellow S., Chopin P., File S.E., and Briley M. Validation of open:closed arm entries in an elevated plus maze as a measure of anxiety in the rat. J. Neurosci. Methods 14 (1995) 149-167
96. Perkins K.L. Cell-attached voltage-clamp and current-clamp recording and stimulation techniques in brain slices. J. Neurosci. Methods 154 (2006) 1-18
97. Porcello D.M., Huntsman M.M., Mihalek R.M., Homanics G.E., and Huguenard J.R. Intact synaptic GABAergic inhibition and altered neurosteroid modulation of thalamic relay neurons in mice lacking δ subunit. J. Neurophysiol. 89 (2003) 1378-1386
98. Purdy R.H., Morrow A.L., Moore Jr. P.H., and Paul S.M. Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat. Proc. Natl. Acad. Sci. 88 (1991) 4553-4557
99. Ramsey I.S., Moran M.M., Chong J.A., and Clapham D.E. A voltage-gated proton-selective channel lacking the pore domain. Nature 440 (2006) 1213-1216
100. Rey M., Carlier E., and Soumireu-Mourat B. Effects of corticosterone on hippocampal slice electrophysiology in normal and adrenalectomized BALB/c mice. Neuroendocrinology 46 (1987) 424-429
101. Rivera C., Voipio J., Payne J.A., Ruusuvuori E., Lahtinen H., Lamsa K., Saarma M., and Kaila K. The K-Cl cotransporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 397 (1999) 251-255
102. Romeo R.D., Karatsoreos I.N., and McEwen B.S. Pubertal maturation and time of day differentially affect behavioral and neuroendocrine responses following an acute stressor. Horm. Behav. 50 (2006) 463-468
103. Romeo R.D., Lee S.J., and McEwen B.S. Differential stress reactivity in intact and ovariectomized prepubertal and adult female rats. Neuroendocrinology 80 (2004) 387-393
104. A receptor subtypes. Nature 401 (1999) 796-800
105. Safranski T.J., Lamberson W.R., and Keisler D.H. Correlations among three measures of puberty in mice and relationships with estradiol concentration and ovulation. Biol. Reprod. 48 (1993) 669-673
106. Sahuque L., Kullberg E.F., McGeehan A.J., Kinder J.R., Hicks M.P., Blanton M.G., Janak P.H., and Olive M.F. Anxiogenic and aversive effects of corticotrophin releasing factor (CRF) in the bed nucleus of the stria terminalis of the rat: role of CRF receptor subtypes. Psychopharmacology 186 (2006) 122-132
107. Sanna E., Mostallino M.C., Busonero F., Talani G., Tranquilli S., Mameli M., Spiga R., Follesa P., and Biggio G. Changes in GABA-A receptor gene expression associated with selective alterations in receptor function and pharmacology after ethanol withdrawal. J. Neurosci. 23 (2003) 11711-11724
108. Sanna E., Mostallino M.C., Murru L., Carta M., Talani G., Zucca S., Mura M.L., Maciocco E., and Biggio G. Changes in expression and function of extrasynaptic GABA-A receptors in the rat hippocampus during pregnancy and after delivery. J. Neurosci. 29 (2009) 1755-1765
109. Saxena N.C., Neelands T.R., and Macdonald R.L. Contrasting actions of lanthanum on different recombinant gamma-aminobutyric acid receptor isoforms expressed in L929 fibroblasts. Mol. Pharmacol. 51 (1997) 328-335
110. Schmidt P., Nieman L., Danaceau M., Adams L., and Rubinow D. Differential behavioral effects of gonadal steroids in women with premenstrual syndrome. New Engl. J. Med. 338 (1998) 209-216
111. A receptor mediated currents in human brain. Eur. J. Neurosci. 24 (2006) 1157-1160
112. Shen H., Gong Q.H., Aoki C., Yuan M., Ruderman Y., Dattilo M., Williams K., and Smith S.S. Reversal of neurosteroid effects at alpha4-beta2-delta GABA-A receptors triggers anxiety at puberty. Nat. Neurosci. 10 (2007) 469-477
113. Shen H., Gong Q.H., Yuan M., and Smith S.S. Short-term steroid treatment increases delta GABA-A receptor subunit expression in rat CA1 hippocampus: pharmacological and behavioral effects. Neuropharmacology 49 (2005) 573-586
114. Smith S.S., and Gong Q.H. Neurosteroid administration and withdrawal alter GABA-A receptor kinetics in CA1 hippocampus of female rats. J. Physiol. 564 (2005) 421-436
115. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 392 (1998) 926-929
116. A receptor α4 subunit in association with increased anxiety. J. Neurosci. 18 (1998) 5275-5284
117. Smith S.S., Ruderman Y., Frye C.A., Homanics G.E., and Yuan M. Steroid withdrawal in the mouse results in anxiogenic effects of 3alpha,5alpha-THP: a possible model of premenstrual dysphoric disorder. Psychopharmacology 186 (2006) 323-333
118. Spigelman I., Li Z.W., Liang J., Cagetti E., Samzadeh S., Mihalek R.M., Homanics G.E., and Olsen R.W. Reduced inhibition and sensitivity to neurosteroids in hippocampus of mice lacking the GABA(A) receptor delta subunit. J. Neurophysiol. 90 (2003) 903-910
119. Stell B.M., Brickley S.G., Tang C.Y., Farrant M., and Mody I. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABA-A receptors. Proc. Natl. Acad. Sci. 100 (2003) 14439-14444
120. Stell B.M., and Mody I. Receptors with different affinities mediate phasic and tonic GABA (A) conductances in hippocampal neurons. J. Neurosci. 22 (2002) RC223
121. Sundstrom-Poromaa I., Smith D.H., Gong Q., Sabado T.N., Li X., Light A., Wiedmann M., Williams K., and Smith S. Hormonally regulated α4β2δ GABA-A receptors are a target for alcohol. Nat. Neurosci. 5 (2002) 721-722
122. Sundstrom I., Nyberg S., and Backstrom T. Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17 (1997) 370-381
123. Turner J.H., and Raymond J.R. Interaction of calmodulin with the serotonin 5-hydroxytryptamine2A receptor. A putative regulator of G protein coupling and receptor phosphorylation by protein kinase C. J. Biol. Chem. 280 (2005) 30741-30750
124. van Broekhoven F., Backstrom T., and Verkes R.J. Oral progesterone decreases saccadic eye velocity and increases sedation in women. Psychoneuroendocrinology 31 (2006) 1190-1199
125. Voituron N., Frugiere A., Gros F., Macron J.M., and Bodineau L. Diencephalic and mesencephalic influences on ponto-medullary respiratory control in normoxic and hypoxic conditions: an in vitro study on central nervous system preparations from newborn rat. Neuroscience 132 (2005) 843-854
126. Wafford K.A., Thompson S.A., Sikela J., Wilcox A.S., and Whiting P.J. Functional characterization of human GABA receptors containing the α4 subunit. Mol. Pharmacol. 50 (1996) 670-678
127. Wallner M., Hanchar H.J., and Olsen R.W. Ethanol enhances α4β2δ and α6β3δ GABA-A receptors at low concentrations known to affect humans. Proc. Natl. Acad. Sci. 100 (2003) 15218-15223
128. Waselus M., Valentino R.J., and Van Bockstaele E.J. Ultrastructural evidence for a role of gamma-aminobutyric acid in mediating the effects of corticotrophin-releasing factor on the rat dorsal raphe serotonin system. J. Comp. Neurol. 482 (2005) 155-165
129. Wei W., Faria L.C., and Mody I. Low ethanol concentrations selectively augment the tonic inhibition mediated by δ subunit-containing GABA-A receptor in hippocampal neurons. J. Neurosci. 24 (2004) 8379-8382
130. Wei W., Zhang N., Peng Z., Houser C.R., and Mody I. Perisynaptic localization of delta subunit-containing GABA (A) receptors and their activation by GABA spillover in the mouse dentate gyrus. J. Neurosci. 23 (2003) 10650-10661
131. Wisden W., Laurie D.J., Monyer H., and Seeburg P. The distribution of 13 GABA-A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J. Neurosci. 12 (1992) 1040-1062
132. Wohlfarth K.M., Bianchi M.T., and Macdonald R.L. Enhanced neurosteroid potentiation of ternary GABA (A) receptors containing the delta subunit. J. Neurosci. 22 (2002) 1541-1549
133. Wu Y., Wang W., and Richerson G. GABA transaminase inhibition induces spontaneous and enhances depolarization-evoked GABA efflux via reversal of the GABA transporter. J. Neurosci. 21 (2001) 2630-2639
134. Yonkers K.A. Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?. J. Clin. Psychiatry 58 (1997) 62-69
135. Zheleznova N., Sedelnikova A., and Weiss D.S. Alpha1-beta2-delta, a silent GABA-A receptor: recruitment by tracazolate and neurosteroids. Br. J. Pharmacol. 153 (2008) 1062-1071